All In Biotech

Free tool

FAERS Monitor: Ativan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018140 or its brand name (Ativan, Lorazepam). Reports on generic versions are filed under their own applications.

Reports

180,741

Serious

139,049

77% of reports

Hospitalization

75,378

Death reported

26,091

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue13,956
  • nausea13,776
  • drug ineffective12,685
  • diarrhoea10,751
  • off label use10,745
  • dyspnoea9,576
  • anxiety9,118
  • headache8,993
  • pain8,962
  • vomiting8,920
  • dizziness8,419
  • asthenia7,347
  • death6,866
  • fall6,628
  • insomnia6,474

Reports by year received

View as table
YearReports
20043,054
20053,435
20063,344
20073,141
20083,345
20094,196
20105,682
20116,022
20127,365
20135,867
20146,989
201510,425
201611,232
201711,734
201813,417
201913,188
202012,712
202111,112
202210,402
20239,527
20249,573
20258,976
20265,997

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,873,418 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anxietySignal9,1183.83.718,612
insomniaSignal6,4742.92.87,816
fallSignal6,6282.32.35,086
astheniaSignal7,3472.32.25,383
vomitingSignal8,9202.22.26,079
fatigueSignal13,9562.12.18,264
nauseaSignal13,7762.02.07,496
dyspnoea9,5762.01.94,729
dizziness8,4192.01.94,116
diarrhoea10,7512.01.95,080
pain8,9621.71.72,670
headache8,9931.71.62,508
off label use10,7451.41.41,450
drug ineffective12,6851.11.1176
death6,8660.90.941

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.